About

GCure aims at unlocking the Research & Innovation (R&I) potential of the University of Coimbra (UC) in Biomolecular Medicine. The actions involve establishing an ERA Chair dedicated to next-generation Gene Therapy Vectors, building upon UC's strong foundation in Gene Therapy research at the Center for Neuroscience and Cell Biology (CNC-UC), and strengthening GeneT - Gene Therapy Center for Excellence Portugal, both part of CIBB - Centre for Innovative Biomedicine and Biotechnology.

The specific objectives of GCure include:

• to create a core R&I cluster on next-generation Gene Therapy Vectors,
• to optimize UC's viral vector production facility,
• to establish a training program on Gene Therapy knowledge & technology transfer,
• to expand UC's participation in collaborative R&I projects,
• to enhance UC's international recognition in the field.
• to attract international researchers to UC,
• to foster a sustainable research group and enhancing resources.
• to improve UC's research and innovation performance,
• to attract high-value collaborations and funding opportunities.

In-house reforms in research management and open science strategies, coupled with a robust training program, will maximize GCure's contribution to the knowledge-based economy and society. GCure represents a strategic endeavor to propel UC to the forefront of Gene Therapy research and innovation, fostering significant advancements in healthcare and well-being.

To achieve these goals, renowned gene therapy pioneer R. Jude Samulski has been appointed GCure ERA Chair holder. Samulski's expertise and achievements in the field, including multiple FDA-approved gene therapies and numerous patents, ensure leadership in advancing UC's Gene Therapy initiatives.

Grant agreement ID: 101186929

Esquema de Financiamento: HORIZON-WIDERA-2023-TALENTS-01-01 - ERA Chairs

Funded under Widening participation and spreading excellence

Start Date: 1 January 2025

End Date: 31 December 2029

All information at CORDIS.